1,143
Views
0
CrossRef citations to date
0
Altmetric
Food Science & Technology

Bio-evaluation of alkaloids and saponins from bitter melon: Probing more desirable compound in treating hyperglycemia and hyperlipidemia

, ORCID Icon, , , , , , ORCID Icon, & ORCID Icon show all
Article: 2242634 | Received 03 Dec 2022, Accepted 26 Jul 2023, Published online: 28 Sep 2023
 

Abstract

Bitter melon is a medicinal plant with wide-ranging health benefits. Being complex in chemical constituents, poor evidence is available to establish the exact therapeutic benefits of different phytochemicals present in bitter melon. In the present study, bitter melon fruit skin, flesh, seeds and whole fruit were assessed to estimate alkaloid and saponin contents and subsequently bio-evaluation was performed to ascertain their potential as more potent hyperglycemic and hyperlipidemic moderators for the first time. For the feeding trial, Sprague-Dawley rats were used. Bitter melon seeds have a high amount of total alkaloids, while the flesh part has maximum total saponin contents. The group of rats fed with a diet containing seeds powder showed a more prominent impact in lowering blood glucose levels and increasing serum insulin concentration in hyperglycemic and hyperlipidemic rats. The flesh part with maximum saponin contents exhibited a substantial impact in lowering cholesterol, LDL and triglycerides and increasing HDL levels. The antihyperglycemic and antihyperlipidemic activities have a direct association with the presence of these chemical constituents. Alkaloids were found to be more potent antihyperglycemic while saponins were found to be antihyperlipidemic moderators.

Acknowledgments

The authors acknowledge the Nutritional Labs of Government College Women University, Faisalabad, Pakistan, for facilitation of collecting data in this study. We are also thankful to the Food Analysis Lab of Government College University Faisalabad, Pakistan, and the Agricultural Extension Directorate, MAAR, Damascus, Syria, for providing lab facilities.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available on request from the corresponding author.

Additional information

Funding

No funding was received to undergo the study.